Insmed reported $1.15M in Ordinary Share Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acelrx Pharmaceuticals ACRX:US $ 0.12M 0M
Alexion Pharmaceuticals ALXN:US $ 0M 0M
Alimera Sciences ALIM:US $ 0.07M 0.01M
Arena Pharmaceuticals ARNA:US $ 0.01M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Cytokinetics CYTK:US $ 0.07M 0M
Dynavax Technologies DVAX:US $ 0.11M 0M
Flexion Therapeutics FLXN:US $ 50K 0
Heron Therapeutics HRTX:US $ 1.02M 0.1M
Insmed INSM:US $ 1.15M 119K
Mirati Therapeutics MRTX:US $ 0.05M 0M
Novartis NVS:US $ 913M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vertex Pharmaceuticals VRTX:US $ 2.59M 0M